NDIANAPOLIS, IN – May 4, 2011 – Vertellus, a leading specialty chemicals company, today announced price increases for DEET (N,N-diethyl-m-tolouamide). Effective June 1, 2011, or as contracts will allow, Vertellus is raising DEET prices by 12%. The move is being driven by rapidly increasing up-stream raw material prices based on crude oil including meta-tolouic acid and metaxylene.

Indianapolis, IN – April 26, 2011 – Vertellus (the “Company”), a leading specialty chemicals company, today announced that the Company will host a conference call to discuss its first quarter 2011 financial results for the period ended March 31, 2011 on Thursday, May 5, 2011 at 11:00 AM EDT. Hosting the call will be Richard Preziotti, President and Chief Executive Officer, and Philip Gillespie, Chief Financial Officer.

The earnings statements and 10-k statement will be available on the Company’s investor webpage on Monday, May 2, 2011.

Instructions for obtaining access to the conference call for interested and qualified investors, as well as the earnings statements, are available on the Company’s investor website at www.vertellus.com. About Vertellus

Vertellus is a specialty chemicals company focused on the manufacture of ingredients used in pharmaceuticals, personal care, nutrition, agriculture, and a host of other market areas affected by trends favoring “green” technologies and chemistries. Vertellus is the #1 global producer of pyridine and picolines, specialty pyridine derivatives, DEET, castor oil derivatives and systems and the world’s #2 producer of Vitamin B-3 and citrate polymer additives. Vertellus benefits from a technically advanced global manufacturing base and has approximately 800 employees. Vertellus is headquartered in Indianapolis, Indiana. Vertellus is owned by Wind Point Partners, a private equity firm based in Chicago. Wind Point acquired Vertellus in 2007 through Wind Point VI, a $715 million fund.

Indianapolis, IN – March 25, 2011 – Vertellus (the “Company”), a leading specialty chemicals company, today announced that the Company will host a conference call to discuss its fourth quarter and full year 2010 financial results for the period ended December 31, 2010 on Monday, April 4, 2011 at 11:00 AM EDT. Hosting the call will be Richard Preziotti, President and Chief Executive Officer, and Philip Gillespie, Chief Financial Officer. The earnings statements and 10-k statement will be available on the Company’s investor webpage on March 31, 2011.   Instructions for obtaining access to the conference call for interested and qualified investors, as well as the earnings statements, are available on the Company’s investor website at www.vertellus.com.

INDIANAPOLIS, IN – January 14, 2011 – Vertellus (“Vertellus” or “the Company”) and Vapi Products Industries Pvt. Ltd. have formed a joint venture in India that will manufacture and distribute specialty chemicals globally. The joint venture company is “Vapi Products Pvt. Ltd.” and is proposed to be renamed Vertellus Specialty Materials (India) Pvt. Ltd. Financial terms of the agreement were not disclosed.

Vertellus is the majority partner and will operate the venture’s manufacturing facility in India. “This strategic joint venture will enable us to maintain our market growth and meet increasing customer demands for sulfone monomers and derivatives alongside other key products,” said Rich Preziotti, President and CEO of Vertellus. “This joint venture is a great fit for Vertellus and is a logical next step in our aggressive global acquisition strategy. By combining the assets and production capacity of Vapi Products Industries with the market reach and technology of Vertellus, we are confident of a smooth and rapid integration process.”

“India is an important market for Vertellus,” continued Preziotti. “This move will provide a catalyst for growth in India across the Company and we look forward to serving local customers as we expand our presence in multiple application fields including pyridine chemistry and pharmaceutical ingredients.”

Establishing a physical presence in India is the first step in enabling Vertellus to work more closely with its existing customers in this important growth market for pharmaceutical intermediates and many other products. This will position the Company to leverage its global asset base to be a better development and supply partner to local companies.

Sulfones monomers and derivatives are important intermediates for the production of polysulfone and polyethersulfone high-performance polymers.

Vertellus manufactures sulfone monomers and derivatives at its facility in Seal Sands UK and will continue to do so after the transaction. This expansion in capacity will consolidate Vertellus’ existing position as a leading supplier of sulfone monomers and derivatives and enable it to provide customers with a combination of quality, capacity and security of supply that makes Vertellus an ideal partner for future growth.

Indianapolis, IN October 26, 2010 – Vertellus (the “Company”), a leading specialty chemicals company, today announced that the Company will host a conference call to discuss its third quarter 2010 financial results for the period ended September 30, 2010 on Thursday, November 4 at 10 AM EST. Hosting the call will be Richard Preziotti, President and Chief Executive Officer, and Philip Gillespie, Chief Financial Officer. The earnings statements will be available on November 3, 2010

Instructions for obtaining access to the conference call for interested and qualified investors, as well as the earnings statements, are available on the Company’s investor website at https://vertellus.com.